Using microarray analysis, we showed up-regulation of Toll-like receptors 1,2,4,7,8, NF-, TNF-, p38-MAPK and MHC molecules in human peripheral blood mononuclear cells following infection with Plasmodium falciparum. We report herein further studies based on time-course microarray analysis with focus on malaria-induced host immunity. Results show that in early malaria; selected immunity-related genes were up-regulated including and  interferon related genes, as well as genes of IL-15, CD36, chemokines (CXCL10, CCL2, S100A8/9, CXCL9, and CXCL11), TRAIL and IgG Fc receptors. During acute febrile malaria, up-regulated genes included  and  interferon related genes, IL-8, IL-1 IL-10 downstream genes, TGFB1, oncostatin-M, chemokines, IgG Fc receptors, ADCC signaling, complement-related genes, granzymes, NK cell killer/inhibitory receptors and Fas antigen. During remission, genes for NK receptors, immunoglobins, and granzymes/perforin were up-regulated. When viewed in terms of immunity type, malaria infection appeared to induce a mixed TH1 response, in which α and β interferon driven responses appear to predominate over the more classic IL-12 driven pathway. In addition, TH17 pathway also appears playing a significant role in the immunity to Plasmodium falciparum. Gene markers of TH17 (neutrophilrelated genes, TGFB1 and IL-6 family (oncostatin-M)) and TH (IFN- and NK cytotoxicity and ADCC gene ) immunity were up-regulated. Initiation of  immune response was associated with an IFN- response which ultimately resulted in IFN-γ achieved via a pathway different from the more classic IL-12 TH1 pattern. Based on these observations, we speculate that in Plasmodium falciparum infection, T and TH17 immunity may predominate over more traditional TH1 response.
Introduction
Host immunity may involve one or a combination of pathways. It has been suggested that TH1 immunity, initiated primarily by IL-12, may play an important immunological role in defense against viruses and intracellular bacteria/parasites, while TH2 responses, driven by IL4, have been shown to be more important against helminthes 1 . TH17 immunity is elicited against extracellular bacteria and this recently described host immunity pathway, is thought to be triggered by TGF-β working in tandem with IL-21 or IL-6 2 . Dendritic cells are important antigen processing cells and play an important role in stimulating both innate and adaptive immune responses to viruses, fungi and bacteria 3 .
In these cells, IL-12 is up-regulated following infection with E. coli and
Candida albicans, but not influenza virus. In contrast, interferon alpha/beta is upregulated after infection with influenza virus, but not E. coli and Candida albicans. These observations suggest that IL-12 and IFN-αβ may help drive different immune response maturation pathways 3 . It is not clear at this time as to which pathway may predominate in the host response to Plasmodium falciparum (P. falciparum) infection.
TH1 has been suggested to be the dominant and protective immune response against malaria both in rodents and humans [4] [5] . Yet, the blood stage of P. falciparum can serve to immunosuppress the host's immune response to the liver stage of the parasite 6 .
Dendritic cell maturation is inhibited by P. falciparum infected RBCs 7 ; monocyte maturation is also suppressed by malaria pigments (hemozoin), and low serum IL-12 was reported in severe malaria [8] [9] . These observations suggest that the IL-12 driven TH1 IFNg dominant response patterns seen following P. falciparum infection may not be functioning optimally; thus, against this background data; one may ask how the infected host is capable of mounting an effective TH1 response against the blood-borne stage of this parasite? An alternative pathway may be needed to achieve this host immune response.
To gain a better understanding of host immune response patterns associated P.
falciparum infection in humans, we carried out transcriptional profiling using microarray analysis of peripheral blood mononuclear cells (PBMCs) after P. falciparum infection.
Our earlier analysis showed an up-regulation of gene expression for Toll-like receptor signaling, NF-kB, TNF-, IFN-, IL-1, p38 MAPK, MHC class I & II molecules 10 . In this study, we further analyzed the data focusing on the specific type or types of host immunity induced by infection. Results indicated an up-regulation of TGF-β and the IL-6 family gene (oncostatin M), both of which induce TH17 immunity. We also observed an elevation in the expression of interferon gamma, NK cell cytotoxicity, antibodydependent cell cytotoxicity (ADCC), which are triggered by interferon alpha/beta (TH), instead of IL-12 (TH1). These results suggest multiple immune pathways may be activated following infection with P. falciparum. For the purposed of this thesis we have classified these additional pathways as: TH and TH17 immunity. The THαβ pathway is not generally recognized within the immunology community as a distinct T cell maturation pathway while the TH17 response pattern has only recently been recognized 11 . However, THαβ responses in which α and β interferons drive a succession of cellular process leading to mid-moderate IFN-γ production and NK cell and ADCC activation have been described in the host response to viruses but they have not been shown to play an important role in the maturation of the anti-malaria adaptive immune response.
To further clarify this point, traditionally TH1 leads to immunity against intracellular bacteria and protozoa; and THαβ against viral infections. Macrophage activation is characteristic of traditional TH1 immunity, while NK activation (natural cytotoxicity & ADCC) is more characteristic of TH immunity. Thus, malaria infection appears to be somewhat unique in that it appears to elicit a combined response reflective of both TH17
and THαβ host immunity.
Material and Methods

Previous analysis
Subject recruitment, sample collection and preparation, and RNA purification were described previously in Ockenhouse and Hu's paper. Briefly, two groups of subjects were recruited for this study after Johns Hopkins University Institutional Review Board and US Army HSRRB ethical approvals were obtained. In the study cohort, 22 subjects, 20-45 years of age, were recruited from the Walter Reed Army Institute of Research (WRAIR). Subjects agreed to receive mosquito bites from laboratory-reared Anopheles stephensi infected by P. falciparum (3D7 strain). Once parasitemia was detected in the subjects's peripheral blood, these subjects received treatment with chloroquine. Blood samples were drawn during the un-infected baseline period (U) and again, when parasitemia was found for the first time (Early malaria) (E).
In the other study cohort, 15 adults were recruited from Cameroon, Africa. These subjects were 19-49 years of age with acute P. falciparum infection. All suffered from typical relapsing fever and blood smears showed parasitemia. These subjects received at least one week of anti-malarial drug treatment (Cotecxin). Blood drawing was performed during the acute febrile infection period (A) and one month later during the remission period (R). During the remission period, physical exams and blood smears were performed to ensure that malaria symptoms were no longer present and parasitemia was no longer detectable.
In the first study cohort, PBMCs were separated from whole blood samples by
Ficoll-gradient at WRAIR. In the second study cohort, blood was collected in CPT tubes and PBMCs were isolated after centrifuge. A RNA stabilizing reagent-RNA later (Ambion, CA, USA) was added and samples were shipped to the USA on dry ice. Total RNA was extracted from both sets of samples using Trizol. The quality of sample RNA was estimated by spectrometry (OD>1.8) and gel electrophoresis.
Microarray preparation
Affymetrix U133A GeneChips (Affymetrix, Santa Clara, CA) were used in this study. The GeneChips contain 22,283 probe-sets, including 14,500 known wellcharacterized human genes and 18,400 transcripts. Before chip hybridization, a QIAGEN RNeasy cleanup kit was used to purify total RNA. Processing of templates for analysis on the Affymetrix U133A GeneChip was performed in accordance with methods described in the Affymetrix Technical Manual, Revision Three. Total RNA from the blood samples were hybridized into the arrays. Detailed cDNA preparation, in vitro transcription, staining, and scanning of Affymetrix U133A GeneChips were described previously in Chris Ockenhouse and Wanchung Hu's paper.
Data analysis
We used GeneSpring software and GeneSpring default normalization to perform one-way ANOVA tests, using un-infected samples as baseline. Significantly up-regulated genes were selected if false discovery rate (FDR) was <0.05 and fold change was >1.5x
when compared to un-infected baseline. These genes were placed into three groups based on expression levels in different stages of the infection. In addition, Pearson's correlation analysis and Rank correlation analysis were performed to find the relationship between expression levels of genes after malaria infection. Pathway analysis was performed by using the Pathway Architect (Statagene Inc.) software to identify the specific immunological pathways involved.
Microarray accession numbers
The Affymetrix data sets can be accessed at http://www.ncbi.nlm.nih.gov/geo/ under the accession number GSE5418.
Results
A total of 2894 genes were differentially expressed out of the 22,283 probe sets in Affymetrix U133A GeneChip based on our criteria of data analysis. Gene expression patterns were measured in individuals with pre-symptomatic experimental early malarial infection and in subjects with naturally-acquired acute febrile malarial infection. A baseline set of data derived from 22 uninfected healthy US subjects was used for gene comparison in samples from early malarial infection, acute febrile malarial infection, and remission stage. This baseline dataset is considered appropriate for comparisons between Cameroonian samples and USA samples because of the difficult in collecting baseline samples from Camerooian subjects that have had no prior exposure to malaria. As indicate previously, the study site in Cameroon is endemic for malaria so it is difficult to find adults in the area that may not already be in the prodromal phase of malaria. 
TH1 immunity related gene up-regulation during malaria
After P. falciparum infection, many immune response-related genes of the TH1 immunological pathway were up-regulated (Table 1) . Although interferon alpha/beta was not detected in this study, the major transcription factor of interferon alpha/beta synthesis, tetratricopeptide repeat 2 (IFIT2). The expression levels of the above genes were greater than 2-fold in early malaria, as compared to un-infection baseline. In acute febrile malaria, the expression levels of most of the alpha/beta interferon genes tended to decline and all returned to baseline levels of expression during the remission period (Table 1 ).
Interferon gamma and many interferon gamma-related genes were also up-regulated after malaria. These observations are consistent with a model in which malaria infection induces primarily a TH1 type immune response. These up-regulated genes included:
interferon gamma, interferon inducible guanylate binding protein 1 (GBP1), interferon inducible guanylate binding protein 2 (GBP2), Janus kinase1 (JAK1), and transporter with antigen processing 1 (TAP1). The expression levels of GBP1, GBP2, and TAP1
ranged from 10.6 to 2.8 fold above baseline during early stage of malaria, and the expression level of GBP2 was greater than 2-fold change during acute febrile malaria.
These interferon gamma inducible genes all returned to baseline levels of expression during the remission periods of the disease. The up-regulation of a number of TH1 chemokines over the malaria disease course was also consistent with a TH1 model of anti-malaria immunity. Up-regulated TH1 related chemokine genes included: CXCL10, CCL3, CCL3 and CCR1. The expression levels of CXCL10 (5.3 fold) was highest during the early phase of malaria, while CCR3, and CCL4 were higher during febrile and recovery stages of the disease (Table 1) . Although macrophage/monocyte activation is traditionally considered to be a strong marker for classic TH1 type immunity, we surprisingly found that express levels of most macrophage activation genes were relatively unchanged or slightly suppressed after P. falciparum infection ( Table 2 ). These data support the hypothesis that there may be two pathways involved in the induction of TH1 types of immune responses: a TH interferon driven path and IL-12 driven path. (See Discussion Section). Most macrophage activation and proliferation related genes were un-changed. (Table 2 ) IL-12 is clearly the major cytokine needed to initiate a strong classic TH1 type immune response, and IL-12 expression levels remain unchanged over the course of this study (Table 2 ). This in NK cell was all up-regulated (Table 1 ) . Also, DAP12 up-regulation can suppress Fc receptor signaling in macrophages, so it is less likely that these up-regulated Fc receptors belong to macrophages. Although IL-10 itself was not up-regulated, many IL-10
downstream genes were up-regulated ( Figure 1 ). IL-10 can activate NK cells and deactivate macrophages. HMOX1 is the major downstream effector molecule to mediate IL-10 inhibition of macrophages. HMOX1 was up-regulated after malaria. HMOX1
generates CO molecule to mediate anti-inflammatory effects in macrophages, which is opposite to iNOS, which generates NO molecule to cause inflammatory effects.
Argininesuccinate synthetase (ASS) is the rate-limiting enzyme to synthesize arginine; the substrate of iNOS. iNOS is the central mediator representing macrophage classical activation; and un-changed ASS and iNOS express levels support the notion that macrophages are not being activated after malaria infection. In our study, macrophages were inhibited rather than activated after malaria. In summary, many elements of TH1 immunity were up-regulated following infection with P. falciparum, including: interferon alpha/beta inducible genes, interferon gamma inducible genes, NK cell related genes (NK cell cytotoxicity), ADCC related genes, TH1 chemokines, and CD8 T cell related genes.
However, macrophages appear to become deactivated and do not appear to proliferate after malarial infection.
TH17 immunity related gene up-regulation during malaria
A number of genes associated with the new described TH17 immunity pathway were up-regulated after infection with P. falciparum (see Table 3 ). Of these genes, IL-8
showed the greatest degree of up-regulation over the entire course of the disease cycle (early, febrile period and remission periods), with expression levels peaking during the febrile period of illness (8.5 fold increase; see Table 3 ). Other up-regulated genes included other TH17 related cytokines, IL1, TGF1, and oncostatin M [OSM], as well as TH17 related transcription factors, CEBP delta, and CEBP gamma. In addition, selected neutrophil-related genes were also up-regulated, including: neutrophil attracting chemokines, S100A9, CXCL2, and CXCL3, the neuterophil-related CD molecules, ICAM1, the NADPH oxidases gene NCF1, and acute reaction protein, PGE synthetase2.
Many complement related genes were also up-regulated including C3A receptor1, C5
receptor1, Delay-accelerating factor (DAF), and Factor D.
TH2 immunity related genes unchanged during malaria
Most TH2 immunity related genes were remarkably unchanged over the course of the malaria disease cycle (Table 4 ). An extensive analysis of TH2 cytokines and chemokines, as well as Mast cell and eosinophil genes revealed that gene expression level were essentially unaffected by infection with P. falciparum; thus providing strong evidence that TH2-type immunity was not significantly initiated during malaria in this study. Expression levels for only a single gene involved in Mast cell activation, Fc epsilon receptor 1A surface receptor, was modified during the malaria disease cycle.
This gene was down-regulated during early malaria and mildly up-regulated during remission period.
Gene-to-gene relationship
We (Table 5) .
Rank correlation has also been done, but there were no significant results. Rank correlation is more strict than Pearson's correlation. If the data is normally distributed,
Pearson's correlation analysis is more suitable than Rank correlation analysis.
Immunological pathways
Pathway analysis was conducted to explore immunological genetic circuitry Figure 4 shows a sketch of the major pathways of host immunity that are felt to play a role in recovery from malaria based on the observations made in this study, as well as those made by other investigators in previous research. The changes in their expression levels during the early, acute, and remission stages of P. falciparum infection are summarized in Figure 4 . As shown in Figure 5 , the expression of genes related to TH2 immunity were unchanged following malaria infection; with most changes occurred in genes related to the TH17 and TH driven pathway of anti-malaria immunity.
Validation by plasma and PBMC protein expression
In our previous analysis, we have found out the concordance between transcription of genes and translation of proteins in malarial infection. We demonstrated the similar upregulation of ICAM1 level after malarial infection between microarray RNA result and surface protein expression detected by flowcytometry. CXCL10, CXCL9, and CCL2 chemokine expressions are up-regulated in our microarray finding. The above chemokine proteins are also identified in plasma samples after malarial infection. These results show that our microarray analysis is validated. (Figure 1 )
Discussion
In previous work, we showed that Toll-like receptor signaling genes, NFkB, TNFalpha, IFN gamma, IL-1 beta, p38 MAPK, and MHC I & II genes were significantly upregulated in acute febrile malaria in comparison with un-infected baseline 10 . In this current analysis, we identified more immunology genes, whose expression levels were significantly changed at different time-points over the course of the malaria disease cycle. for inducing TH17 immunity. In this study, TGF-β, IL-1, and IL-8 were strongly upregulated in acute malaria (Table 3) . Although IL-17 was not up-regulated, the IL-6-related cytokine family gene-Oncostatin M was up-regulated in acute malaria infection.
Oncostatin M can up-regulate STAT3, a key mediator in TH17 immunity 14 . Thus, it appears that TH17 immunity can be induced in malaria infection. Up-regulated TGF-, IL-6, or TNF are associated with a higher frequency of malaria complications and an overall poor malaria prognosis. A previous study revealed that neutrophil-related genes were up-regulated in children after acute P. falciparum malaria infection 15 . They also reported up-regulation of IL-6 receptor, C3AR1, C5R1, FPRL1, PBEF, and IL-1 which are important components of TH17 immunity. Neutrophilia has been observed in falciparum malaria, and elevated WBC counts are associated with severe malaria 16 . Gene network analysis of TGFB1/IL-6 or IL-17 related gene expression after malaria infection also suggested that malaria was TH17 dependent. Falciparum malaria often causes complications such as acute renal failure and acute respiratory distress syndrome (ARDS).
Neutrophil overactivation in TH17 immunity is thought to play major role in the pathogenesis of cerebral malaria, acute renal failure, and ARDS [17] [18] [19] . Thus, malaria induced TH17 immunity could be related to both malaria-induced cerebral malaria, acute renal failure, and ARDS.
Evidence for dividing the more traditional TH1 immunity pathway into two subtypes (THαβ and TH1 immunity) comes primarily from both mouse and human models of malaria immunity. The major difference separating TH1 immunity and TH immunity are the effector cells involved. In the mouse model, interferon alpha/beta suppresses macrophage proliferation and neutrophiles and NK cells play a more prominent role, in contrast, IL-12 enhances macrophage proliferation [20] [21] . In addition, interferon alpha/beta increases NK cell blastogenesis, so alpha/beta interferon enhances NK cell proliferation 22 . Thus, interferon alpha/beta and IL-12 mediated immunological events can be distinguished by the different effector cells they enhance, NK cells or macrophages.
Both IL-12 and interferon alpha/beta can induce CD4 T cells to secret interferon gamma. Interferon alpha/beta can induce CD4 T cells to produce both interferon gamma(+) and IL-10(+++). These interferon gamma and IL-10 secreting CD4 T cells were previously called a type 1 regulatory T cells because IL-10 has some antiinflammatory effect. However, if these types of T cells are purely immuno-regulator cells, it cannot explain why there is interferon gamma production from these CD4 T cells. IL-10 is not a pure immunosuppressant because it can stimulate NK cells, B cells and CTLs.
In fact, the regulatory effect of these Tr1 cells could be due to cross-regulation between Tr1 cells and other T helper cells such as TH1, TH2, and TH17 cells. In a prior mouse study, interferon alpha/beta can substitute for IL-12 in the induction of interferon gamma production associated with the development of TH1 immunity 23 . In mice, interferon alpha/beta can also induce B cell isotype switching to produce IgG antibody 24 . IL-10 can stimulate B cell to produce IgG1 antibody and IFNg can stimulate B cells to produce IgG3 antibody. Interferon alpha/beta can also cause cross-priming of CD8 T cells 25 . Both interferon alpha/beta and IL-12 can serve as a third signal to facilitate clonal expansion of antigen specific CD8 T cells 26 . Again in mice, interferon alpha/beta can suppress the proliferation of IL-17 secreting CD4 T cells 2 . These observations in mice strongly suggest that interferon alpha/beta can induce an alternative TH1 immunity without the need of IL-12. In addition, interferon alpha/beta suppresses the induction of nitric oxide synthetase (iNOS) 27 . iNOS is the central effector molecule involved in the killing of ingested bacteria and parasites by macrophages. Activation of iNOS is a basic tenet of classic macrophage activation. iNOS activation has been shown to enhance the intracellular killing capability of macrophages by a 1000-fold 28 . iNOS can also be induced by interferon gamma through IL-12 mediated up-regulation. IL-10 can also serve as a strong macrophage de-activator. It can suppress macrophage proliferation, iNOS activation, and macrophage cytokine production. It can also suppress IL-12 production.
Thus, interferon alpha/beta and IL-12 should be seen as belonging to different inductive immunological pathways. immunity cannot be triggered in natural malarial infection in human to clear out the protozoa, malaria parasites can cause severe illness in human.
In human, there is also a substantial amount of evidence indicating that TH1 immunity can be induced by two pathways driven by αβ interferon or IL-12 33 .
Administration of IL-12 to human subjects suppresses NK cell proliferation 34 .
Macrophage activation serves to inhibit NK cell function; while NK cell activation serves to inhibit macrophage proliferation 20, 35 . Given these observation it is reasonable to speculate that these two effector cells belong to different immunological pathways.In the present study, we found that a number of genes involved in the NK cell proliferation were up-regulated over the course of the malaria disease cycle (Table 1 ). In addition, as in the mouse model, genes associated with macrophage proliferation were not up-regulated following infection with P. falciparum. Increased NK cell populations have also been reported previously in acute malaria infection [36] [37] . Thus, it appears that the interferon alpha/beta-NK cell pathway of THαβ immunity is preferentially enhanced after P. falciparum infection; while the IL-12 driven pathway appears unaffected. Other TH related cytokines also can cause NK cell activation or proliferation including IL-10 and IL-15, respectively.
In human, interferon alpha/beta has been shown to enhance NK cell cytotoxicity as well as antibody dependent cell cytotoxicity (ADCC) 38 , but IL-12 administration suppresses NK cell cytotoxicity and ADCC 39 . In addition, IL-12 induces NK cell to secret high levels of interferon gamma to activate macrophages instead of activating NK cell's cytotoxicity machinary 22 . In the current study, Fc receptors, alpha/beta interferon and ADCC related genes were up-regulated after malaria infection. Consistent with this model, patients with defects in NK cell production usually suffering from recurrent virus infections and have more complications following malaria infection 40 41 .
Further evidence that interferon alpha/beta can trigger TH1 immunity without the need for IL-12 comes from other human studies, in which, interferon alpha/beta suppressed STAT6 expression which is related to IL-4 induction and expression of TH2 immunity 42 . In our study interferon alpha/beta inducible genes were clearly up-regulated to induce THαβ immunity with ADCC; while TH2 related gene expression remained unchanged. In human models, interferon alpha/beta inhibits IL-12 production via an IL-10 dependent mechanism 43 . Thus, it seems reasonable to speculate that IL-12 and interferon alpha/beta do not belong to the same immunological pathway.
In human malarial infection, it has been shown that serum IL-12 levels are inversely correlated with malaria parasitemia 9 . The more severe the malaria is, the lower IL-12 expression levels become. The up-take of malarial pigment (Hemozoin) can downregulate IL-12 secretion in human monocytes 8 . Malarial PGE2-like molecules can also down-regulate IL-12 secretion 44 . Up-regulation of CD36 by malarial infection can inhibit dendritic cell maturation with decreasing IL-12/IL-10 ratio 7 . Although hemozoin, in certain studies, can activate TLR9 which is for traditional TH1 immunity, TLR9 is not detected in our study. In previous microarray analysis of human malarial infection, interferon inducible genes were up-regulated with un-changed IL-12 expression 15, 45 .
Other important components of TH immunity included up-regulation of HMOX1, FAS, BCL6, TNFRSF10A, and MIP1 were noted in Griffiths'research which studied the peripheral blood leukocytes from Kenyan children with acute falciparum malaria. In this microarray study, we found up-regulation of interferon alpha/beta, interferon gamma, falciparum is characterized by a suboptimal THα/β and TH17 bias which predominates over the more ideal and effective traditional TH1 responses driven by IL-12. Since treatment for malarial infection faces some difficulty like drug resistance, we strongly encourage to use IFNg(FDA approval drug) or IL-12 for malarial infection treatment to achieve the optimal host immunity to kill the intracellular protozoa. Red color means greater than 2-fold change; yellow color means 1.5-2-fold change; green color means no change blue color means down-regulation 
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